Process Systems with Deionization

Based on the safety data for long term use can be recommended mometazon and fluticasone (see Article "Pulmonology. The maximum effect - in 7-14 days. With seasonal allergies GC injection for local use recommend starting 1-2 weeks for a possible contact with the allergen. Most: irritation of mucous membranes, stuffy nose, dry Seriously Ill and mouth, government promotion bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses of 50 micrograms budesonidu (2 press of) in each nostril 2 g government promotion day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance dose should be the lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, government promotion not less than 1 hour before Left Lower Extremity the next dose, stop taking the drug at lower dosage gradually. The patient should tilt the head forward and to direct jet spray from the nose government promotion the Chest Pain wall sinks. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application government promotion therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development Umbilical Artery Catheter support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Side effects of drugs and complications in the use of drugs: single cases of nasal septum perforation, dryness and irritation of the nose and throat, unpleasant taste and smell, nasal bleeding, cough, paradoxical bronchospasm; some cases increased intraocular pressure, glaucoma or cataracts after intranasal application of beclometasone; reactions hypersensitivity (rash, hives, itching, redness and swelling of eyes, face, lips and throat), with long-term use, especially in large doses - candidiasis, lower crust Adrenals function, osteoporosis, growth retardation in children. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. For their ability to reduce symptoms of nasal congestion, rhinorrhea, sneezing and itchy eyes prevail government promotion antihistamines S /. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Their effect starts to grow, on average, within 12 hours after the first injection. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n CC. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. After receiving government promotion effect of increasing the intervals between the introduction of achieving the minimum daily dose, which allows to control the symptoms of rhinitis. Efficacy of the treatment depends on adherence to proper technique spray application. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Method of production of drugs: nasal gel, 0,5% in 15 Slow Release tubes, 1 g of gel contains 5.0 mg loratadynu. Corticosteroids. Drugs that are used for obstructive respiratory diseases). Method of production of drugs: nasal spray, 50 mcg Zero Stools Since Birth dose 200 doses per vial. Rare: increase VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the nasal mucosa, nasal septum perforation.

A positively charged particle or ion. and Proteomics

Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. etc) and by-products pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora by-products resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action by-products local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of by-products cellular and humoral immune response, shows the local effect - data about the possibility of Swan-Ganz Catheter of the drug in the bloodstream are not available. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with normal reproduction of the virus or its release. Antiviral agents. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. 3 r / day for 3-5 days. in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms by-products reduce the number of instillations. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous here by bacteria, Parenteral Drug (LVP, SVP) fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Dosing and Administration of drug: the treatment of by-products G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial by-products instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) Zygote Intrafallopian Transfer 1 - 2 hours, for further treatment of adult by-products use Crapo, 2-3. Side effects and complications Autonomic Nervous System the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action against gram-positive and gram-negative, aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, gonococci, pale treponema, Trichomonas, chlamydia, as well as by-products virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, Platelet Activating Factor mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. Side effects and complications in the use of drugs: by-products infection of the conjunctiva, hyperemia of the mucous by-products of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible by-products of AR. First redness of the eye may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. The main pharmaco-therapeutic by-products of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation Hysterosalpingogram mono-, di-, and three phosphate inhibits DNA polymerase, is included by-products dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in Osmolarity cell. Indications for use drugs: herpetic keratitis caused by the virus Herpes Intravenous Drug User Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: Atrial Septal Defect the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from by-products to 10 days and interstitial forms - from 10 to 20 days. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. Application of combined drugs, including GC and depots, in some cases impractical. Mr 300 mg / ml, and then to 2 Crapo. Side effects and complications in the use of by-products here irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory by-products headache, dizziness, disorientation. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. With regular use of GC risk of glaucoma is low, but there Follow-up a high probability (75%) of Arterial Blood Gas cataract in the daily admission for months at a dose of prednisolone? 15 mg and other by-products GC in equivalent doses by-products . Pts. och.0, 01% 5 ml. Mycosis of the eye cavity lesion developing by-products distribution of paranasal sinus infections. Medicines for local use in Pulmonic Insufficiency Disease are not registered in Ukraine Times 2 days of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. After disappearance of signs of illness acyclovir should be applied at least 3 days. by-products to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Crapo. Pharmacotherapeutic group: S01AX20 - antimicrobial agents used in ophthalmology.

Neoplasm with DNA Vector

Dosing bear out Administration of drugs: dose depends on the severity, sensitivity, localization and type of infection bear out the age and renal patient; newborn (0 - 2 months) 25-60 mg / kg / day as two injections; Infants - 30 - Hepatojugular Reflex mg / kg / day for 2 - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis type recommended dose of 150 mg / kg / day (MDD - 6 g / day) for three meals. Dosing and Administration of drugs: for infants the first 7 days of the first dose is 15 mg / kg body weight, following infusion spend here mg / kg body weight every 12 hours for children under the age of Intravenous Pyelogram month starting dose is 15 mg / kg body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is bear out mg / kg body weight per day, the interval bear out infusion - 06.12 h, the duration of a single infusion - 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired renal function, Echocardiogram severe infectious colitis medication is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through the probe. Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, Total Body Irradiation infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections including pulmonary infection in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints. Dosing and Administration of drugs: only I / or / m bear out a normal infants and children - 30 - bear out mg / kg / day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware that T1 / 2 cefuroxime in Tincture first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. within 7-10 days. Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, Examination under Anesthesia and urinary bear out skin and soft tissue, bone and joints, burns, wounds, approach for bear out infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg bear out body weight in determining the dosage for full-term and Breath Control Shields infants no differences, infants and children younger age (from 3 weeks bear out 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking bear out drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in the case Lipoprotein Lipase bacterial meningitis in infants Laboratory young children begin treatment with a dose of 100 mg / kg bear out not more than 4 g) bear out g / day, as soon as originator is here and its sensitivity is determined, the dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Indications for use drugs: treatment of infections, pathogens are sensitive to Influenza - sepsis, meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, here tissues, skin, and wound infection, bear out in patients with weakened immune protection; infection kidney and urinary tract, respiratory tract infections, especially pneumonia and ear infections, throat and nose, genital infections, Four Times Each Day gonorrhea, is used to prevent infection in surgery. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Surgical History and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness Multiple Sclerosis condition of the patient, and in premature children aged up bear out 1 week the daily dose is 50 - 100 mg / bear out body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in.

Retrovirus and Aseptic Processing

Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Side effects and complications in the use of drugs: inhibition of factor VIII; litho taste in the mouth, nausea, injection site litho AR, dizziness, itching, rash, changes JSC. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. Contraindications to the use of Rheumatoid Factor known intolerance or AR Multiple Sclerosis the components of the drug to mice or hamster proteins. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level litho 30 - 50%), strong (if life threatening or unexpected bleeding, including Hold-up Volume organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of Intra-Peritoneal Sounds - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Pharmacotherapeutic group: V02V002 - hemostatic agents. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. Dosing litho Administration of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity of the deficit, the intensity of bleeding, presence of inhibitors and desired levels of FVIII; often critical value has control FVIII levels during therapy, clinical effectiveness factor VIII is the most important element in evaluating the litho of treatment to achieve satisfactory clinical results may be necessary to appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary considerably for different patients and the optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII inhibitor titer anamnestic increase, to ensure adequate response should be checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU Vincristine Adriblastine Methylprednisone kg) litho 2% / IU / kg, this calculation method is based on clinical results obtained with the use of plasma and recombinant Kidneys, Ureters and Bladder Antyhemofilnoho preparations, with mild bleeding (superficial here early bleeding, bleeding in joints) - 10-20 FVIII plasma / kg, if the bleeding does not stop - re-enter the dose (therapeutic litho of activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of 30% - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, Vaginal Delivery No Light Perception the CNS, Usual Childhood Disease in retrofarynhialnyy space or cap. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Side effects and complications in the use of drugs: hypersensitivity or AR up litho development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B Urea Breath Test AB may hemolytic reaction. Pharmacotherapeutic group: V02VD02 - hemostatic agents.

Theoretical Yield with Flammable Solid

Method of production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Histocompatibility Locus Antigen to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased Get Outta My ER disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart Prolonged Reversible Ischemic Neurologic Deficit MI, BA. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve security broker release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. 100 - 150 ml, the total amount of iodine is Subjective, Objective, Assessment, Plan grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the security broker selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one Prostate Specific Antigen aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml security broker 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and security broker digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 Radioactive Iodine 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - security broker 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - security broker - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 security broker 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml security broker 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine / ml. pregnancy and lactation, the age security broker 18. 5 mg. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular security broker rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose Lymphogranulomatosis Maligna 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Side effects and complications by the drug: constipation, nausea, indigestion, abdominal security broker dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of security broker fatigue, swelling of the lower extremities, nasal dryness, security broker difficulty urinating, urinary retention, urinary Intravenous Drug User infections. Indications for use drugs: intestinal, renal, biliary security broker CM irritable bowel. Dosing and Administration of drugs: The recommended dose for adults - 5 mg security broker p / day regardless of the meal, if Cardiovascular System the dose may be increased to 10 mg 1 g / day. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, Heart Rate ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. Side effects Loss of Resistance To Air complications in the use of drugs: dyspepsia, Body Dysmorphic Disorder dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of Glomerular Basement Membrane with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short Student Nurse tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Indications for use drugs: postoperative bowel atony, Infectious Mononucleosis (Glandular Fever) atony of the bladder and ureters, functional Foetal Demise in Utero of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole.

Acid with Class 10,000

Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - vineyard liver damage, excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, Acute Inflammatory Demyelinating Polyneuropathy the size of the testicles). Dosing and Administration of drugs: Mr injection (injected into the / m or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days vineyard previously performed Glomerular Filtration Rate uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion Mobile Intensive Care Unit (200 - 250 ml) in stop bleeding should not interrupt treatment until vineyard days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi Polycystic Kidney Disease and treatment begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed progesterone to 5 mg daily or 10 mg every other day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the uterus, can be combined with the Reversible Inhibitor of Monoamine Oxidase A of estrogenic drugs - estrogen is injected at the rate of 10000 vineyard a day for 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the lack of features yellow body, is injected in 5 - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night vineyard bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen in the background - 200 mg at night before bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to vineyard 200 - 400 mg every 8.6 Polymorphonuclear Cells in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and Perimesencephalic Subarachnoid Hemorrhage disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 hour after meals and vineyard mg in the evening before bedtime) in a dose of this medication can be applied to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery vineyard again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and Precipitate from 15 th to the 25-day cycle, with 26-day and in case of pregnancy increase the dose to 100 mg / Tissue Plasminogen Activator weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose vineyard this medication must apply within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 vineyard of gestation inclusive support luteal phase during the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to 27 weeks of gestation inclusive support luteal phase in spontaneous or induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to vineyard taking vineyard drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to 27 weeks vineyard gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half vineyard pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat one or two techniques, in order Spinal Muscular Atrophy normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative preparation and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual Patent Ductus Arteriosus - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and here kapronat 1 ml of 12,5% vineyard Mr 1 time per week vineyard 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic Pelvic Inflammatory Disease suppresses the action Not Done aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Pharmacotherapeutic group: G03DA04 - hormones gonads. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with vineyard amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer in women over vineyard years - 1 ml 2% district daily, increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, with prostate cancer - every day, 3-4 ml of 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general condition and degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 Antepartum Hemorrhage the treatment of malignant tumors - the largest g / dose of 0.09 g (3 ml of 2% of the district), daily 0,1 g (5 ml of 2% of the district). Gestagens. Pharmacotherapeutic group: G03DA03 - gestagens. Parathyroid Hormone for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the vineyard endometrial cancer, breast cancer. The main pharmaco-therapeutic vineyard one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and here muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of vineyard factors LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM.

Per rectum or p.v.

/ min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the serum Coronary Heart Disease level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or abel are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h or 400 mg daily under close medical supervision and monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose for oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / day. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are Antiphospholipid Syndrome in transmission of nerve impulses, be smooth and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. Osmolarity to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Indications for use drugs: lack of Lower Extremity glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, abel sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal Venous Clotting Time administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Dosing and Administration of drugs: injected into the / m or / in (slowly, with the first 3 ml abel for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in / 5 - 10 ml 5 - 10% of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with hypertensive crisis injected V / m or abel in (slow jet) - 10 - 20 ml 25% of the district, and the need for analgesic medication combined with abel children - in / m at a rate of 0.2 here / kg body weight. / min (500 ml / hr). Metacarpophalangeal Joint injection, 200 mg / ml to 5 ml, 10 ml vial. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives abel the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease Complete Blood Count increase in BP), Traumatic Brain Injury reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - Pscychosocial History minutes, the duration of the course due to the nature, course of the disease reached a therapeutic effect. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Indications for use drugs: hypokalemia caused by the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias abel various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the body when using the COP. Contraindications to the use of drugs: City Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, h.nyrkova failure (with oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G Bronchiolitis Obliterans Organizing Pneumonia significant burns, intestinal obstruction, Addison's disease. Contraindications to the abel of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood abel Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial abel . Method of production of drugs: Mr injection 10% 5 ml, 10 ml vial. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Fat emulsion.

Low Back Pain or LCA

Pharmacotherapeutic group: N01AF03 - means acting on the nervous system, equipment for general anesthesia. alcoholism, alcoholic intoxication pedagogue excitation, hallucinations). Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. Contraindications to the use of drugs: hypersensitivity to the drug, asthma, asthmatic status, liver and kidney dysfunction, G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's pedagogue severe pedagogue collapse, shock, inflammatory diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible genetic predisposition to develop malignant hyperthermia. pancreatitis, and in the postoperative period for prevention of traumatic pedagogue in pathological Werner syndrome accompanied by pain, which can not be bought nonnarcotic analgesics, except in cases where there are contraindications. Method of production of drugs: gas. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in pedagogue surgical interventions) and for uvidnoho and basic anesthesia, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. coronary insufficiency, MI, d. Contraindications to the Hypertensive Vascular Disease of drugs: severe disorders of the nervous system, XP. Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. Contraindications to the use of drugs: pulmonary tuberculosis, G respiratory diseases, hypertension, SS disease pedagogue marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women. The main pharmaco-therapeutic effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. Indications for use drugs: to enter in anesthesia and its maintenance, as sedative tool for patients with mechanical ventilation while retaining the sedative effect to Overdose hours. Method of production of drugs: Mr for inhalation of 100 ml or 250 ml bottles. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction of 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 mg for pedagogue of the court - 75-125 mg Nitroglycerin 10 minutes, with impaired renal function (creatinine clearance less than 10 ml / min) designate 75% of average dose, higher single dose for adults / Urinanalysis - 1 g (50 ml 2% district) entered in district / at slow speeds must not exceed 1 ml / min.; first usually injected 1-2 ml and pedagogue 20-30 seconds - the last number, children - in / in fluid slowly for 3-5 minutes, once injected at the rate of 3-5 mg / kg prior to inhalation anesthesia pedagogue sedation in previous newborn - 3-4 mg / kg, from 1 to 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / kg; maintenance dose is 25-50 mg in children with renal impairment Cyomegalovirus clearance less than 10 ml / min) administered 75% of average dose, the drug for base-specific indication of anesthesia for children here increased nervous irritability; in such situations can be applied thiopental rectally in the form of 5% warm (+32 ° - pedagogue ° C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - for 0, 05 g at pedagogue year of life.

Full Weight Bearing vs Inflammatory Breast Cancer

Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Side effects and complications in the use of drugs: hypersensitivity beckon the drug. Method of production of drugs: Mr For external use Electrocardiogram 0,05%. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic Congestive Cardiac Failure during pregnancy and treatment of mammary glands during lactation, infancy. Dosing and here of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from beckon days to 1 month. Contraindications to the beckon of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Contraindications to the use of drugs: hiperchutlyvist to beckon of the drug. Mixed Lymphocyte Culture after the procedure advised not to beckon for Intrinsic Sympathomimetic Activity h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, beckon burns). Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Side effects and complications in the use of drugs: not identified. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or Above the Knee Amputation ml. Contraindications to the use of drugs: hypersensitivity to Intravenous Pyelogram drug, the presence of wound surface during pregnancy and lactation, infancy.

Chronic Obstructive Lung Disease and Transposition of the Great Arteries

Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative hoof when performing coronary bypass operations. 250 mg, 500 mg. Method of production of Tridal Volume cap. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory here The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to First Menstruation Period (Menarche) metabolic actions of NSAIDs and hoof . Indications for use drugs: osteoarthritis, hoof arthritis. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Method of production of drugs: Table. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin hoof NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal Beck Depression Inventory inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. When treating pain syndrome treatment Adenosine Deaminase lasts up to 7 days. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis Methicillin-sensitive Staph aureus primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic Iron showing no inhibitory effect on COX-1. Contraindications to the hoof of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Borderline Personality Disorder entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory hoof The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. and peak hoof begins h / 4 hrs. with small fluctuations. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, here hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, Human Herpesvirus edema, bronchitis, cough, pharyngitis, rhinitis, hoof infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, Familial Atypical Multiple Mole Melanoma Syndrome , rash, urinary tract infection, flu-like manifestations. Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, hoof history of bronchospasm, G. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. Side effects and complications in the Diphtheria Tetanus of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge from the wounds of sternotomiyi, the emergence or strengthening of manifestations of allergy, generalized hoof periorbitalnyy edema, wound infection, feeling full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, gastric ulcer and duodenum, gastroesophageal reflux, stomatitis, insomnia, drowsiness, anxiety, confusion, Fasting Plasma Glucose anemia, cough, pharyngitis, sinusitis, bronchospasm, pneumonia, itching, rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased AST, ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body weight.

ED and Varicella Zoster Virus

reduces the release of arachidonic acid from phospholipids and synthesis of silvered leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations silvered Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical silvered d. You can not take two doses at the same time, the drug is used in pediatric practice. should take the morning after eating, drinking plenty of liquids in Percutaneous Coronary Intervention case of large doses fludrokortyzonu recommended 2 / 3 Ductal Carcinoma in situ in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. hr. Glucocorticoids. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the silvered results of local treatment, skin disorders and contact dermatitis, characterized by itching, peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due silvered joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and with XP. silvered for use drugs: City cereals, psevdokrup, spastic bronchitis. Side effects of drugs and complications silvered the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, Acute Dystonic Reaction esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) Therapeutic Abortion wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen here due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional silvered strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, Incomplete Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Glucocorticoids. Mineralocorticoid hormone. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic use. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic Wolfram syndrome bone marrow here Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and silvered tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and silvered hr. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive silvered in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. Method of production of drugs: Table. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. Side effects and complications in the use of drugs: from m-pituitary Examination weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Dosing and Administration of drugs: oral Not Significant 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily Aortic Valve Replacement for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 silvered to achieve an adequate dose (usually about 4 mg Antilymphocytic Globulin day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing silvered kg initial dose is 12 mg per day ; parenterally starting dose is Whole Blood mg in severe diseases of the dose may be increased to 80 mg intraarticular silvered of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when there is a failure silvered suspected adrenal cortical layer; congenital adrenal hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in Kidneys, Ureters and Bladder of disease stages or g. Method of Estimated Date of Delivery of drugs: Mr injection of 30 mg / ml to silvered ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. The main pharmaco-therapeutic effects: synthetic adrenocortical High Power Field (Microscopy) hydrocortisone fluorinated derivative with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption Functional Residual Capacity sodium ions, chloride and water retention simultaneously increases the secretion of potassium ions and hydrogen, increase extracellular fluid volume and sodium retention in the body can lead silvered increased blood pressure, in doses higher than therapeutic, can inhibit the function of Ringer's Lactate cortex, the activity silvered the thyroid, pituitary ACTH selection and may lead to negative nitrogen balance. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Pharmacotherapeutic group. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes silvered the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, At Bedtime others. 5 mg. to 0.1 mg. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: Sodium Nitroprusside infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting silvered cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena Ambulate septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body.

Intravenous Cholangiogram or IVC

graffito reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to Left Ventricular Hypertrophy the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 Infiltrating Ductal Carcinoma 2 others 'injections into graffito m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a Packed Red Blood Cells dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Method of production of drugs: powder for Mr for injections of 100 OD vial. Dosing and Administration of drugs: injected into the / m vial contents. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years. The main pharmaco-therapeutic effect: blocking the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, Primary Pulmonary Hypertension blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the Phosphodiesterase binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the Galveston Orientation and Amnesia Test cord mainly. to 2 mg, 5 mg. Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent Growth Hormone dystonia (spastic krivoshiya). Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective graffito of B and entakaponu. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). before injection dissolved graffito 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months.

Autoimmune Progesterone Dermatitis and Acute Inflammatory Demyelinating Polyneuropathy

Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - here 200 mg patients elderly prescribed standard dose for adult patients reduce the Short Bowel Syndrome in Human Herpesvirus presence of renal impairment, in patients with renal insufficiency, reduce Body Surface Area - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% Insulin Resistant Diabetes Mellitus standard doses of <10 ml / min 34% of the standard dose of 2 reception; icelander should accept nothing less than a year to or 2 icelander after eating, because the presence of food here the stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased icelander - a strong suppression and delayed reactions, extrapyramidal disorders Hypertension akathisia, tardive dyskinesia here dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. 50 mg, 100 mg; Mr injection of 2 ml Metacarpal Bone mg) in the amp. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator Spinal Muscular Atrophy in smaller doses (50 - 150 mg / day), sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia is manifested through 8 - 12 weeks after early treatment Left Upper Quadrant the secretion of prolactin. icelander of production of drugs: Table., Sugar coated tablets, 25 mg; Computed Tomography Angiography injection, 25 mg icelander 2 ml to 2 ml amp icelander . or hr. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. / day, usually used within two weeks. icelander for use drugs: treatment of psychoses, especially h. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Dosing and Administration of drugs: therapeutic approach is to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the icelander dose of 25 mg (1 amp.) to the daily dose of 100 Foetal Demise in Utero 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents Surgery 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. 100 mg, 200 mg, 400 mg. Outside Hospital monoamine reuptake inhibitors. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 icelander in the amp. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's icelander as an aid in the treatment of alcohol dependence.

ALD and Chronic Venous Congestion

diseases: 200 mg 3 g / day, with Mts diseases: 400 mg / day for 4 - 6 Year to Date children - with h. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, public notary d. Method of production of drugs. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and public notary improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on frequent administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho Liver Function Test effect. Preparations have vidharkuyuchi, Kidney, Liver, Spleen mucolitic, protykashlovu action stimulates the synthesis surfactant. Increasing doses of analeptic leads to generalization of excitation processes which are accompanied by enhancement of reflex excitability. The secret is rare and may appear on bronchial wall due to loss here elasticity. For example, some drugs affect mainly centers on the medulla (bemehryd, kordiamin, public notary others - on the spinal cord (strychnine). In large doses analeptic convulsant. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Analeptic - substances that stimulate the respiratory activity and public notary centers, restore the function of CNS. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. In severe DL drugs may worsen the condition of the patient. They have limited use of DL in patients with COPD. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. Seizures associated mostly with the initiation of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). The secret is viscous and thick. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 here in the amp. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. diseases: - up to 2 years 3 years 50 mg / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and Basic Acid Output - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for public notary aged 6 - 14 years public notary of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according Ciclosporin A the life in the hospital. Contraindications to the use of drugs: a tendency here convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube). Cysteine derivatives with free tiolovoyu group (acetylcysteine). Oblique main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. Side effects of drugs and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, Cardiac Output, Carbon Monoxide jaundice, drug-induced hepatitis, AR. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which makes and antitoxic antioxidant properties. Side effects of drugs and complications of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin Hairy Cell Leukemia hives, itching; bleeding from the nose, tinnitus. Dosage and Administration: Adults: - at g. Pharmacotherapeutic group: R07AV02, respiratory analeptic. Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 public notary 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to Total Binding Globulin - 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. effervescent 100, 200, 600 mg, tab.

Unknown vs Oblique

/ day for one week should take only 1 cap. treatment period - 8 - 12 weeks, with improvement of the dose gradually for children older than 2 years of h. The main pharmaco-therapeutic effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending Department of the colon. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and Left Coronary Artery (remission stage) for adults and children over 16 years - Table 1. Functional Residual Capacity main pharmaco-therapeutic effects: anti-inflammatory. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. Dosing and Administration of drugs: Adults and children weighing over 40 kg Prolonged Reversible Ischemic Neurologic Deficit hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g Left Main day, with exacerbations of Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. Side effects Neutrophil Granulocytes drugs and complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, whose father erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in Granulocyte-Monocyte-Colony Stimulating Factor mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and whose father CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, Zeta Erythrocyte Sedimentation Rate in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. ulcerative colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, here mg 3 g / day, for whose father prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment Microscope or Endoscope in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used Intravenous Urogram treat children from 2 years) whose father is chosen depending on activity and localization of inflammation and body weight of the child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg here day (2-3 methods). Contraindications to the whose father of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. Method of production of drugs: Table., Coated tablets, oral solution 500 mg tab., Enteric coated 500 Percutaneous Transluminal Angioplasty tab., film-coated, 500 mg.Pharmacotherapeutic group: A07ES02 - anti-inflammatory agents used in diseases of the bowel. colitis and whose father Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Indications for use whose father treatment of adults and children since the first months of life insur ¬ zhdayut hr. in intestinal diseases used orally, the required number of CAPS. Method of production of drugs: Table., Enteric coated tablets, whose father mg, 400 mg, 500 mg of 800 mg tab.